Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.82% is in line with its 5-year average of 0.90%, near the low end of its 5-year range (0.57%–4.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.61% below its 12-month average of 1.22%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.82%.
DEBT TO ASSETS RATIO
0.82%
DEBT TO ASSETS RATIO AVG TTM
1.22%
DEBT TO ASSETS RATIO AVG 3Y
0.94%
DEBT TO ASSETS RATIO AVG 5Y
0.90%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-32.61%
CURRENT VS 3Y AVG
-12.74%
CURRENT VS 5Y AVG
-8.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+812.92%
vs the sector median at left
ORIC Pharmaceuticals, Inc.
Market Cap
$1.23B
Debt to Assets Ratio
0.82%
TTM Avg
1.22%
3Y Avg
0.94%
5Y Avg
0.90%
Market Cap
$1.21B
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.20B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.20B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.18B
Debt to Assets Ratio
0.45%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.31B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ORIC Pharmaceuticals, Inc. (ORIC) | $1.23B | 0.82% | 1.22% | 0.94% | 0.90% |
| Cronos Group Inc. (CRON)vs › | $1.22B | 0.00% | N/A | N/A | N/A |
| Omada Health (OMDA)vs › | $1.23B | 0.00% | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.21B | 0.16% | N/A | N/A | N/A |
| Kardigan, Inc. (KARD)vs › | $1.20B | 0.02% | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | 0.00% | N/A | N/A | N/A |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.20B | 0.01% | N/A | N/A | N/A |
| MannKind Corporation (MNKD)vs › | $1.18B | 0.45% | N/A | N/A | N/A |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | 0.11% | N/A | N/A | N/A |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.31B | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.8%
Debt/Equity
0.01
Current Ratio
13.19
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.82% |
| 2026-03-31 | 0.75% |
| 2025-12-31 | 2.81% |
| 2025-09-30 | 0.77% |
| 2025-06-30 | 0.94% |
| 2025-03-31 | 1.32% |
| 2024-12-31 | 1.16% |
| 2024-09-30 | 1.03% |
| 2024-06-30 | 0.84% |
| 2024-03-31 | 0.79% |
| 2023-12-31 | 4.01% |
| 2023-09-30 | 0.99% |
| 2023-06-30 | 0.93% |
| 2023-03-31 | 1.18% |
| 2022-12-31 | 4.83% |
| 2022-09-30 | 1.11% |
| 2022-06-30 | 1.01% |
| 2022-03-31 | 0.74% |
| 2021-12-31 | 0.64% |
| 2021-09-30 | 0.57% |
| 2021-06-30 | 0.60% |
| 2021-03-31 | 0.65% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
